Continue Reading
Full article on Bloomberg
Obesity Category Still Hot: Mizuho's Jared Holz
{# Share Buttons Partial Variables: share_title — text to pre-fill in share dialogs share_url — canonical URL to share (use request.build_absolute_uri in parent) #}Market Intelligence Analysis
AI-Powered
Why This Matters
Mizuho Securities' Jared Holz believes there may be another bid from Pfizer in the obesity category, citing indirect hints from the company.
Market Impact
Market impact analysis based on bullish sentiment with 80% confidence.
Sentiment
Bullish
AI Confidence
80%
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Jared Holz, Mizuho Securities Healthcare Equity Strategist, says he wouldn’t be surprised to see one more bid from Pfizer. He tells Katie Greifeld and Matt Miller on “The Close” that Pfizer made it clear without saying so directly that its latest attempt may not be the final one. (Source: Bloomberg)
Original article published by
Bloomberg
on November 5, 2025.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.